What is the projected market size and growth rate for the global AI in genomics market through 2035?

The global AI in genomics market was valued at USD 1,061.32 million in 2024 and is projected to reach USD 68,191.11 million by 2035. This represents a robust Compound Annual Growth Rate (CAGR) of 46.0% during the forecast period of 2025-2035.

Which market segment is currently dominating the AI in genomics industry by component?

Software is the principal market segment. It is indispensable for managing, interpreting, and visualizing massive genomic datasets. These platforms are critical for variant calling, gene annotation, and predictive modeling, with a growing shift toward cloud-based deployment and real-time analytics.

How is machine learning specifically contributing to genomic data interpretation?

Machine learning, particularly deep learning architectures like transformers and graph neural networks, is the primary technology driver. It enables the identification of complex nonlinear relationships in heterogeneous data, achieving high accuracy in variant effect prediction, gene-expression imputation, and regulatory element identification.

What are the primary drivers of growth in the AI in genomics market?

The market is driven by the explosive increase in next-generation sequencing (NGS) data, the rising demand for precision medicine, the need to de-risk expensive pharmaceutical R&D pipelines, and the integration of hardware accelerators like GPUs and TPUs to handle massive computational workloads.

Which region leads the global market, and what factors support its position?

North America currently commands the largest market share. Its leadership is sustained by a mature biotech ecosystem, advanced sequencing infrastructure, significant investment influx, and a high concentration of key players and academic research hubs, particularly in the United States.

What role does Explainable AI play in the clinical adoption of these technologies?

Explainable AI (XAI) is becoming a gold standard for clinical genomics because it provides human-readable rationales for diagnostic and prognostic outputs. This transparency is essential for gaining clinician trust and ensuring compliance with stringent healthcare regulatory frameworks.

How are strategic partnerships between biopharma and tech firms shaping the industry?

Collaborations, such as the partnership between Illumina and NVIDIA or Deep Genomics and Roche, are driving platform consolidation. These alliances integrate specialized AI toolkits directly into sequencing hardware and CRISPR libraries, drastically reducing timelines for variant calling and gene-editing target discovery.

What are the most attractive emerging opportunities within this market?

Key opportunities include multi-omics integration platforms (combining genomics, proteomics, and metabolomics), real-time pathogen genomics for outbreak tracking, AI-guided gene editing optimization, and edge-computing genomics appliances for field-deployable screening.

How is AI transforming the drug discovery and development application segment?

AI is significantly shortening drug development timelines by identifying novel therapeutic targets, modeling molecular interactions, and optimizing clinical trial designs through machine learning-based biomarkers. This improves success rates and enables the creation of personalized treatment regimens.

What are the major challenges hindering the widespread adoption of AI in genomics?

The industry faces hurdles such as the high cost of specialized hardware, concerns regarding patient data privacy and sovereignty, a shortage of interdisciplinary expertise in bioinformatics and data science, and the complexity of integrating AI solutions with legacy laboratory information systems.

Global AI in Genomics Market Size, Trend & Opportunity Analysis Report, by Component (Hardware, Software), Technology (Machine Learning), Functionality (Genome Sequencing, Gene Editing, Others), Application (Drug Discovery & Development, Precision Medicine, Diagnostics, Others), and Forecast, 2025-2035

Report Code: LSDB14Author Name: Isha PaliwalPublication Date: August 2025Pages: 293

Available In:

Global AI in Genomics Market Size, Opportunity Analysis and Forecast, 2025–2035

Publication Date: Aug 11, 2025Pages: 293

Global AI in Genomics Market Size, Opportunity Analysis and Forecast, 2025–2035

Get A Quick Sample Report